Tamiflu is a prescription antiviral medication used to treat and prevent influenza (the flu). Its active ingredient, oseltamivir, works by blocking a key enzyme on the surface of the flu virus, preventing it from spreading to new cells in your body. First approved by the FDA in 1999, it remains one of the most widely prescribed flu treatments and is effective against both influenza A and B viruses. It does not work against the common cold or other respiratory infections.
How Tamiflu Stops the Flu Virus
To understand Tamiflu, it helps to know how the flu virus normally spreads inside your body. When a flu virus infects one of your cells, it hijacks that cell to produce copies of itself. Once those copies are assembled, they need to break free from the cell surface to go infect neighboring cells. The virus uses an enzyme called neuraminidase to cut itself loose. Think of neuraminidase as molecular scissors that snip the bonds holding new virus particles to the cell they were made in.
Tamiflu is a neuraminidase inhibitor. It mimics the shape of the molecule that neuraminidase normally cuts, plugging into the enzyme’s active site and disabling it. With those scissors jammed, newly formed virus particles stay stuck to the surface of the infected cell. They clump together instead of dispersing, and far fewer go on to infect new cells. The virus doesn’t get killed outright, but its ability to spread through your respiratory tract slows dramatically, giving your immune system a chance to catch up and clear the infection.
How Much It Shortens the Flu
Tamiflu doesn’t make the flu disappear overnight. In adults, clinical data shows it shortens symptom duration from about 7 days to 6.3 days, a modest but real reduction. The benefit tends to be more noticeable in children, where symptoms were shortened by an average of 29 hours, though individual results varied widely.
The drug’s real value often lies less in shaving off a day of symptoms and more in reducing the severity of the illness and lowering the risk of serious complications like pneumonia, particularly in people who are at higher risk: young children, adults over 65, pregnant women, and those with chronic health conditions.
Why the 48-Hour Window Matters
Tamiflu works best when started within 48 hours of your first symptoms. This is because of the way viral replication works. In the first day or two of illness, the virus is actively copying itself and spreading from cell to cell at its fastest rate. During this window, blocking neuraminidase has the greatest impact on slowing that chain reaction. Once the virus has already spread widely through your respiratory tract, there are fewer new release events to block, and the drug becomes less effective. That said, treatment started after 48 hours may still offer some benefit for people who are severely ill or at high risk for complications.
Available Forms and Typical Course
Tamiflu comes as capsules (in 30 mg, 45 mg, and 75 mg strengths) and as a liquid suspension for children or anyone who has trouble swallowing pills. For adults and teens 13 and older, the standard treatment course is 75 mg taken twice a day for five days. Children’s doses are calculated by weight, ranging from 30 mg to 75 mg twice daily.
The drug can also be used preventively. If someone in your household has the flu and you want to reduce your own risk of getting sick, a lower dose taken once daily for at least 10 days can be prescribed. During broader community outbreaks, this preventive course can extend up to six weeks. Research modeling suggests post-exposure prophylaxis reduces the risk of developing influenza by roughly 64%.
Common Side Effects
The most frequent side effect is nausea. In clinical trials, about 10% of adults taking Tamiflu experienced nausea (compared to 6% on placebo), and roughly 9% had vomiting (compared to 3% on placebo). Children were somewhat more likely to vomit: 14% on Tamiflu versus 8.5% on placebo. Taking the medication with food can help reduce stomach discomfort.
A more unusual concern involves neuropsychiatric effects. Post-marketing reports have documented rare cases of self-injury and delirium in people taking Tamiflu, with the majority of these reports coming from Japanese adolescents and adults. The FDA advises that anyone taking the drug be monitored for abnormal behavior, especially children and teenagers. These events are rare, but worth being aware of.
Viral Resistance
Like all antivirals, Tamiflu faces the possibility that flu viruses can mutate to resist it. The World Health Organization tracks resistance patterns globally, and the primary mutation of concern is a specific change in the neuraminidase enzyme (known as H275Y) found in certain H1N1 strains. So far, widespread resistance has not emerged in seasonal flu, but it is monitored closely, particularly in avian influenza strains like H5N1 and H7N9 that occasionally infect humans. For most seasonal flu cases, Tamiflu remains effective.
What Tamiflu Does Not Do
Tamiflu only works against influenza viruses. It has no effect on COVID-19, RSV, the common cold, or other respiratory illnesses that can feel similar to the flu. This is why getting a confirmed flu diagnosis, often through a rapid test at a clinic or pharmacy, matters before starting treatment. Taking Tamiflu for a non-influenza illness won’t help and exposes you to side effects without any benefit. It is also not a substitute for the annual flu vaccine, which remains the primary tool for preventing influenza in the first place.